Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 5,762 shares at $28.53 ($164K) on 2025-12-22, disclosed to the SEC on 2025-12-29.
Open-market sale of $164k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.53 | 2,881 | $82K | 50.0% |
| 2 | $28.53 | 2,881 | $82K | 50.0% |
| Total | $28.53 avg | 5,762 | $164K | 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |
| OLMA | SELL | 2024-12-11 | $294K | — | Filing → |